Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362557904> ?p ?o ?g. }
- W4362557904 endingPage "3203" @default.
- W4362557904 startingPage "3203" @default.
- W4362557904 abstract "Human health is experiencing several obstacles in the modern medical era, particularly cancer. As a result, the cancer therapeutic arsenal should be continually expanded with innovative small molecules that preferentially target tumour cells. In this study, we describe the development of two small molecule series (7a-d and 12a-e) based on the 1-benzyl-5-bromoindolin-2-one scaffold that connected through a hydrazone linker to a 4-arylthiazole (7a-d) or 4-methyl-5-(aryldiazenyl)thiazole (12a-e) moiety. The anticancer activity of all the reported indolin-2-one derivatives was assessed against breast (MCF-7) and lung (A-549) cancer cell lines. The 4-arylthiazole-bearing derivatives 7c and 7d revealed the best anticancer activity toward MCF-7 cells (IC50 = 7.17 ± 0.94 and 2.93 ± 0.47, respectively). Furthermore, the VEGFR-2 inhibitory activity for 7c and 7d was evaluated. Both molecules disclosed good inhibitory activity, and their IC50 values were equal to 0.728 µM and 0.503 µM, respectively. Additionally, the impacts of 7d on the cell cycle phases as well as on the levels of different apoptotic markers (caspase-3, caspase-9, Bax, and Bcl-2) were assessed. Molecular docking and dynamic simulations are carried out to explore the binding mode of 7d within the VEGFR-2 active site." @default.
- W4362557904 created "2023-04-06" @default.
- W4362557904 creator A5002297147 @default.
- W4362557904 creator A5008390535 @default.
- W4362557904 creator A5011325212 @default.
- W4362557904 creator A5015977596 @default.
- W4362557904 creator A5022873345 @default.
- W4362557904 creator A5056974586 @default.
- W4362557904 creator A5059783007 @default.
- W4362557904 creator A5067577636 @default.
- W4362557904 creator A5070924066 @default.
- W4362557904 creator A5074371614 @default.
- W4362557904 creator A5085387645 @default.
- W4362557904 date "2023-04-04" @default.
- W4362557904 modified "2023-09-30" @default.
- W4362557904 title "1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights" @default.
- W4362557904 cites W1031578623 @default.
- W4362557904 cites W1493446016 @default.
- W4362557904 cites W1967062678 @default.
- W4362557904 cites W2013931228 @default.
- W4362557904 cites W2018077387 @default.
- W4362557904 cites W2030152799 @default.
- W4362557904 cites W2035266068 @default.
- W4362557904 cites W2049151031 @default.
- W4362557904 cites W2056654402 @default.
- W4362557904 cites W2062610629 @default.
- W4362557904 cites W2064476496 @default.
- W4362557904 cites W2067607490 @default.
- W4362557904 cites W2069509450 @default.
- W4362557904 cites W2081693079 @default.
- W4362557904 cites W2090323663 @default.
- W4362557904 cites W2107440467 @default.
- W4362557904 cites W2108059444 @default.
- W4362557904 cites W2114367386 @default.
- W4362557904 cites W2114918609 @default.
- W4362557904 cites W2126326024 @default.
- W4362557904 cites W2134967712 @default.
- W4362557904 cites W2138787512 @default.
- W4362557904 cites W2144671784 @default.
- W4362557904 cites W2177929699 @default.
- W4362557904 cites W2193437559 @default.
- W4362557904 cites W2400889815 @default.
- W4362557904 cites W2413943215 @default.
- W4362557904 cites W2514059345 @default.
- W4362557904 cites W2586746820 @default.
- W4362557904 cites W2618704048 @default.
- W4362557904 cites W2741343815 @default.
- W4362557904 cites W2744937568 @default.
- W4362557904 cites W2772174090 @default.
- W4362557904 cites W2791536887 @default.
- W4362557904 cites W2792389705 @default.
- W4362557904 cites W2793972506 @default.
- W4362557904 cites W2800422355 @default.
- W4362557904 cites W2802224401 @default.
- W4362557904 cites W2808522316 @default.
- W4362557904 cites W2809674728 @default.
- W4362557904 cites W2810162698 @default.
- W4362557904 cites W2904324362 @default.
- W4362557904 cites W2966600544 @default.
- W4362557904 cites W2982733831 @default.
- W4362557904 cites W2987296346 @default.
- W4362557904 cites W3000169719 @default.
- W4362557904 cites W3001990253 @default.
- W4362557904 cites W3015884307 @default.
- W4362557904 cites W3018056821 @default.
- W4362557904 cites W3034151867 @default.
- W4362557904 cites W3044966413 @default.
- W4362557904 cites W3048821490 @default.
- W4362557904 cites W3081435180 @default.
- W4362557904 cites W3095428811 @default.
- W4362557904 cites W3104927021 @default.
- W4362557904 cites W3108504839 @default.
- W4362557904 cites W3112174167 @default.
- W4362557904 cites W3114544935 @default.
- W4362557904 cites W3117588887 @default.
- W4362557904 cites W3127094332 @default.
- W4362557904 cites W3132974537 @default.
- W4362557904 cites W3133431544 @default.
- W4362557904 cites W3133503305 @default.
- W4362557904 cites W3133878483 @default.
- W4362557904 cites W3155114112 @default.
- W4362557904 cites W3155849694 @default.
- W4362557904 cites W3157881366 @default.
- W4362557904 cites W3162142738 @default.
- W4362557904 cites W3166041257 @default.
- W4362557904 cites W3174684496 @default.
- W4362557904 cites W3176364071 @default.
- W4362557904 cites W3186877437 @default.
- W4362557904 cites W3201492729 @default.
- W4362557904 cites W3206518778 @default.
- W4362557904 cites W4200255327 @default.
- W4362557904 cites W4206841660 @default.
- W4362557904 cites W4214536851 @default.
- W4362557904 cites W4220899322 @default.
- W4362557904 cites W4220976664 @default.
- W4362557904 cites W4224936484 @default.
- W4362557904 cites W4229053187 @default.
- W4362557904 cites W4283466659 @default.